drugset / Trial / NCT01124747
A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug
Non-randomizedSingle-groupOpen-label
Summary
The objective of this study is to assess the systemic disposition of ASP1585 after oral administration of 14C-labeled drug in healthy male subjects.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bixalomer | Small molecule | — | Oral |
Indications
No indication recorded.